Company Performance Metrics
PainVox is a medical technology company that develops radiopharmaceutical diagnostics for chronic pain management. The company’s lead candidate, the PET radiotracer PV-1, also referenced as [18F] FTC-146, is designed to localize peripheral pain generators in patients with complex or refractory pain conditions. PainVox focuses on integrating its
tracer with PET and PET/MR imaging workflows to provide objective visualization of painful tissue and pro-nociceptive pathology via Sigma-1 receptor binding. Its technology is intended to support clinicians in planning image-guided interventions and tailoring treatment strategies across indications such as complex regional pain syndrome, musculoskeletal pain, and pelvic pain. PainVox also provides clinical case data and collaborates with research and clinical partners to advance precision imaging approaches in pain diagnostics.
